GSK NYSE: GSK is pursuing a focused oncology expansion built around hematologic malignancies, gyneco

GSK plc (GSK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

GSK's $750M Chimagen deal adds a trispecific TCE to its multiple myeloma portfolio, targeting two tu

GSK said on Tuesday it had agreed a deal worth up to $750 million ​to buy a trispecific T cell-engag

GSK's Jideytro delivers strong first-line NSCLC results, with high response rates and durable diseas

GSK shares jump over 4% on strong survival data for SCLC drug Ris-Rez and a 94% response rate for Ji

94% objective response rate at 15.2 months follow-up90% of patients were progression free at 12 mont

GSK NYSE: GSK is accelerating investment in research and development, expanding its late-stage pipel

GSK said on Friday it will be shutting down ​a vaccine factory in Dresden, Germany, which ‌its websi

GSK's Specialty Medicines are driving growth, but an approaching HIV patent cliff is pushing the com

GSK plc (GSK) Presents at Bernstein's 23rd Annual Pan-European Strategic Decisions Conference Transc

Analyst ratings and news for high-yield healthcare stocks Medtronic (3.06%), Smith & Nephew (2.7

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Haleon gains US market share at Walmart and Target by securing eye-level shelf placement with aggres

GSK PLC's (LSE:GSK, NYSE:GSK)  experimental mRNA flu vaccine produced data that closely resemble Mod

HUTCHMED stock jumps on a $1.3B GSK deal for its cancer drug HMPL-A830. Learn the financial terms an

HUTCHMED NASDAQ: HCM said it has entered a co-development and licensing agreement with GSK for ex-Ch

Hutchmed (China) Ltd (AIM:HCM, NASDAQ:HCM, HKG:0013, FRA:H7T2) won ringing endorsements from City br

Hutchmed (China) Ltd (AIM:HCM, NASDAQ:HCM, HKG:0013, FRA:H7T2) shares jumped 17% to 210p on Thursday

GSK subsidiary ​GlaxoSmithKline Intellectual Property (No. 4) Ltd will pay ‌a unit of HUTCHMED (Chin

GSK to advance its mRNA flu vaccine into phase III after phase II study has shown stronger immune re

Today's major mRNA headline is a competitive threat to Moderna (NASDAQ:MRNA | MRNA Price Prediction)

GSK's shares are down 14% in six months, but strong Specialty Medicines growth and a robust pipeline

GSK moves its dual-target mRNA seasonal flu vaccine to Phase 3 trials following strong Phase 2 data

GSK said ​on Tuesday ‌it will advance ​its ​mRNA-based seasonal influenza ⁠vaccine ​candidate into ​

GSK PLC Sponsored ADR (NYSE: GSK - Get Free Report) has received a consensus recommendation of "Hold

H2 2026/Q1 2027 will be rich in catalysts. From the potential FDA approval of bepirovirsen, with a t

Two unvaccinated Pennsylvania residents died of measles, the state’s first deaths in 35 years, as tr

Oz says the MMR vaccine is “not a lethal vaccine” after Trump warned the combined shot could be “qui

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

During market turbulence, investors turn to dividend-yielding stocks. Benzinga provides analyst rati

President Donald Trump signed an order Monday limiting core childhood vaccine recommendations to 11

https://youtu.be/H_RititNE8U

The Trump administration is reportedly considering an executive order on vaccines and autism as earl

https://www.gsk.com/en-gb/media/press-releases/cabenuva-demonstrates-superiority-to-daily-oral-thera

GSK beats Q2 revenue and earnings estimates, launches a $2.52B cost-savings program, and updates its

U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting bet

In times of market turbulence, dividend-yielding stocks are popular for investors. Check out analyst

GSK (NYSE:GSK) affirms FY2026 Adj EPS guidance from $4.90-$5.00 to $4.90-$5.00 vs $4.79 analyst esti

GSK (NYSE:GSK) reported quarterly earnings of $1.35 per share which beat the analyst consensus estim

Results add to a growing body of positive late-stage evidence for Ris-Rez, including recent pivotal

GSK Canada today announced the approval of Shingrix (GSK's Recombinant Zoster Vaccine or RZV) in

GSK wins early FDA approval for Jideytro, a targeted treatment for adults with advanced ROS1-positiv

GSK plc (LSE/NYSE:GSK) today announced the US Food and Drug Administration (FDA) has approved Jideyt

Trump says imported generic drugs face 0% tariffs for 2 years, before 100% and then 200% duties.

GSK stops development of chronic cough drug camlipixant after mixed Phase 3 results; continue testin

Investors turn to dividend-yielding stocks during market turbulence. Benzinga's Analyst Stock Ra

GSK Jemperli shows sustained complete responses in dMMR/MSI-H rectal cancer, potentially eliminating

GSK-backed Ris-Rez posts positive Phase 3 survival data in small-cell lung cancer as the company mov

Hansoh Pharmaceutical Group Co., Ltd. (Hansoh Pharma, 03692.HK) today announces that risvutatug reze